We recently developed an immortalized osteoclast (OCL) precursor cell line that forms large numbers of OCLs. This cell line was derived from mice doubly transgenic for bcl-X L and large T antigen that was targeted to cells in the OCL lineage (bcl-X L /Tag cells). We have now characterized these cells in terms of their surface and enzymatic phenotype, responsiveness to osteotropic factors, and differentiation potential. (MNC) in bone that are the primary cells responsible for bone resorption. They are derived from hematopoietic precursors that proliferate and differentiate into OCLs. The final differentiation of OCLs occurs in bone, where mononuclear OCL progenitors in close contact with osteoblasts fuse and form bone-resorbing OCLs. OCLs are rare cells that are difficult to isolate in large numbers for cellular and molecular biology studies. Therefore, we developed immortalized OCL precursors from transgenic mice by targeting transforming genes and antiapoptosis genes into cells of the OCL lineage using the tartrate-resistant acid phosphatase (TRAP) promoter. In our first attempts to produce immortalized OCL precursors, we developed transgenic mice in which simian virus 40 large T antigen (Tag) was targeted to OCLs. However, we were unable to develop immortalized OCL precursors from these mice, probably because apoptosis increased in cells of the osteoclast lineage (1). To overcome this problem, we targeted an antiapoptosis gene, bcl-X L , to cells of the OCL lineage using the same techniques. The bcl-X L gene is a bcl-2-related gene that is expressed in a wide range of cell types and prevents apoptosis both in vivo and in vitro (2-6). By crossing mice transgenic for Tag and bcl-X L , we obtained doubly transgenic mice and succeeded in immortalizing OCL precursors (7). These cells formed OCLs with high efficiency, expressed calcitonin receptors, as shown by RT-PCR and autoradiography, and resorbed bone when cultured on dentine slices. The OCL formation capacity of the bcl-X L /Tag cells was approximately 500 times greater than that of normal mouse marrow. In the current work we characterized this cell line further by studying its surface and enzymatic phenotype, its responsiveness to different osteotropic factors, and its differentiation potential. These data demonstrate that bcl-X L /Tag cells form OCL-like cells that fulfill the phenotypic characteristics of OCLs and show their utility for studies of the molecular events involved in commitment of bipotent precursors to OCLs.
tured with MC3T3E1 cells, with the combination of 1,25-dihydroxyvitamin D 3 and dexamethasone induced high levels of OCL formation. The bcl-X L /Tag cells formed large numbers of OCLs when cultured with RANK ligand and macrophage colony-stimulating factor in the absence of feeder cells. In the absence of RANK ligand and a feeder cell layer, 100% of the cells differentiated into F4/80-positive cells. However, neither PTH nor PTH-related protein enhanced OCL formation by bcl-X L /Tag cells even when they were cocultured with primary osteoblasts, suggesting that they differ from primary mouse bone marrow cells in their responsiveness to PTH/PTH-related protein. Thus, bcl-X L /Tag cells have many of the properties of primary mouse OCL precursors and should be very useful for studies of OCL differentiation and divergence of OCL precursors from the macrophage lineage. (Endocrinology 140: 2954 -2961, 1999) O STEOCLASTS (OCLs) are multinucleated cells (MNC) in bone that are the primary cells responsible for bone resorption. They are derived from hematopoietic precursors that proliferate and differentiate into OCLs. The final differentiation of OCLs occurs in bone, where mononuclear OCL progenitors in close contact with osteoblasts fuse and form bone-resorbing OCLs. OCLs are rare cells that are difficult to isolate in large numbers for cellular and molecular biology studies. Therefore, we developed immortalized OCL precursors from transgenic mice by targeting transforming genes and antiapoptosis genes into cells of the OCL lineage using the tartrate-resistant acid phosphatase (TRAP) promoter. In our first attempts to produce immortalized OCL precursors, we developed transgenic mice in which simian virus 40 large T antigen (Tag) was targeted to OCLs. However, we were unable to develop immortalized OCL precursors from these mice, probably because apoptosis increased in cells of the osteoclast lineage (1) . To overcome this problem, we targeted an antiapoptosis gene, bcl-X L , to cells of the OCL lineage using the same techniques. The bcl-X L gene is a bcl-2-related gene that is expressed in a wide range of cell types and prevents apoptosis both in vivo and in vitro (2) (3) (4) (5) (6) . By crossing mice transgenic for Tag and bcl-X L , we obtained doubly transgenic mice and succeeded in immortalizing OCL precursors (7) . These cells formed OCLs with high efficiency, expressed calcitonin receptors, as shown by RT-PCR and autoradiography, and resorbed bone when cultured on dentine slices. The OCL formation capacity of the bcl-X L /Tag cells was approximately 500 times greater than that of normal mouse marrow. In the current work we characterized this cell line further by studying its surface and enzymatic phenotype, its responsiveness to different osteotropic factors, and its differentiation potential. These data demonstrate that bcl-X L /Tag cells form OCL-like cells that fulfill the phenotypic characteristics of OCLs and show their utility for studies of the molecular events involved in commitment of bipotent precursors to OCLs. 
Materials and Methods

Cytokines and osteotropic hormones used
Antibodies
FITC-conjugated monoclonal antibodies (mAB) against Mac-1, CD45.2, and Ly6G (Gr-1) and phycoerythrin-conjugated mAB against CD80, CD86, CD14, CD11c, Mac-3, CD40, and CD16/CD32 were purchased from PharMingen (San Diego, CA). FITC-conjugated mAB against F4/80 and I-Ab for C57BL/6 major histocompatibility complex type II (MHC II) were purchased from Caltag Laboratories, Inc. (Burlingame, CA).
Culture of bcl-X L /Tag cells
The bcl-X L /Tag cells were prepared as described previously (7) and maintained with MC3T3E1 cells in ␣MEM containing 10% FCS. To determine the growth characteristics of the cells, a fixed number of bcl-X L /Tag cells cultured with feeder cells were plated in four-well plates and cultured for 2, 24, 48, 72, and 120 h. Cells were fixed with acetone-methanol (1:1, vol/vol) for 10 min (8) and stained for Mac-1 as described below, which is only expressed on bcl-X L /Tag cells. In selected experiments, bcl-X L /Tag cells were purified as previously described (7) . Briefly, MC3T3 cells were lysed using a polyclonal antibody prepared against mouse fibroblasts, which also lyses MC3T3 cells. The cells were further enriched by immunoadherence techniques using the Mac-1 antibody (9) . After these purification stages, bcl-X L /Tag cells were more than 98% pure, as assessed by Mac-1 staining.
Messenger RNA (mRNA) preparation from osteoclasts formed by bcl-X L /Tag cells
The bcl-X L /Tag cells were cocultured with MC3T3E1 cells in six-well plates with or without 1,25-(OH) 2 D 3 (2 ϫ 10 Ϫ9 m) and dexamethasone (10 Ϫ7 m) for 7 days to induce OCL-like cell formation. Total RNA was extracted with RNAzol (3 ml/plate; Biotex Laboratories, Inc., Houston, TX) by incubating the cells over ice for 5 min, the lysates were transferred to 15-ml tissue culture tubes, and then 600 l chloroform were added to the tubes. The tubes were shaken vigorously and then centrifuged for 10 min at 4 C for 9000 ϫ g. The upper aqueous phase was collected, and an equal volume of isopropanol was added. The tubes were incubated at Ϫ20 C for 30 min and then centrifuged for 15 min at 4 C at 9000 ϫ g. The supernates were discarded, and the pellets were washed with 500 l 80% ethanol-20% water. RNA was pelleted by centrifugation for 3 min at 4 C in a microfuge and completely air-dried. Finally, the RNA pellets were resuspended in diethylpyrocarbonate-water and stored at Ϫ80 C until needed.
RT-PCR analysis of bcl-X L /Tag cells for expression of MMP9, IL-1 receptor 1 (IL-1R1), and IL-1R2 mRNAs
Total RNA was isolated from highly purified bcl-X L /Tag cells or MC3T3 feeder cells by the guanidinium isothiocyanate method using RNAzol reagent (Biotex Laboratories, Inc.) following the manufacturer's protocol. Approximately 3 g total RNA from each sample were denatured at 65 C for 10 min and reverse transcribed using murine Moloney leukemia virus reverse transcriptase. The reaction volume was 20 l and contained 5 mmol/liter MgCl 2 , 50 mmol/liter KCl, 10 mmol/liter Tris-HCl (pH 8.3), 1 mmol/liter of each deoxy-NTP, 2.5 mol/liter random hexamers, and 1 U ribonuclease inhibitor. The reaction was incubated for 15 min at 42 C, followed by inactivation of reverse transcriptase by heating at 94 C for 5 min. The complementary DNA products obtained were subjected to PCR in a reaction mixture of 100 l containing 2 mmol/liter MgCl 2 , 50 mmol/liter KCl, 10 mmol/liter TrisHCl (pH 8.3), 0.2 mmol/liter of each deoxy-NTP, 2.0 U AmpliTaq DNA polymerase, and 0.1 mol/liter of sense and antisense primers of the following murine gene-specific primers: MMP9 sense primer, 5Ј-TCT GAG GCC TCT ACA GAG TCT-3Ј; antisense primer, 5Ј-CTC ATG GTC CAC CTT GTT CAC-3Ј; IL-1R1 sense primer, 5Ј-GAG TTA CCC GAG GTC CAG-3Ј; antisense primer, 5Ј-GAA GAA GCT CAC GTT GTC-3Ј; and IL-1R2 sense primer, 5Ј-TGC CAG CAG TGC AGC AAG ACTC-3Ј; antisense primer, 5Ј-GGA TGG GTT CCG TGG TTG TTCC-3Ј. The PCR reaction was carried out by incubating the samples at 94 C for 1 min followed by 35 cycles at 94 C for 1 min and 60 C for 1 min, with a final extension for 5 min at 60 C. The amplified products were electrophoresed on a 1.5% agarose gel with a 123-bp DNA ladder (BRL, Gaithersburg, MD) as a size marker. Bands were visualized by ethidium bromide staining.
Immunostaining of osteoclast precursors for Mac-1 and F4/ 80 antigen
The bcl-X L /Tag cells were cultured in the presence or absence of MC3T3E1 cells for 3 days and then fixed either with acetone-methanol (1:1) for 10 min or with 2% glutaraldehyde in PBS for 20 min to stain cells for Mac-1 or F4/80, respectively. Rat monoclonal antibody against mouse Mac-1 antigen was purchased from Boehringer Mannheim (Indianapolis, IN) and the monoclonal antibody against F4/80 antigen from Serotec (Oxford, UK). After fixation, the cultures were incubated in 1% BSA-PBS overnight at 4 C. The cultures were then incubated with the primary antibody (1:100 dilution) for 1 h at room temperature. Cultures were washed four times with PBS and incubated for an additional hour at room temperature with a secondary antibody (biotin-labeled rabbit antirat IgG, DAKO Corp., Glostrup, Denmark) at a 1:100 dilution. After washing with PBS, the cultures were incubated for 1 h at room temperature with peroxidase-conjugated ExtrAvidin (Sigma Chemical Co.,) at a dilution of 1:100. All dilutions were performed using PBS containing 0.1% BSA. Finally, the antigen-antibody conjugates were visualized with diaminobenzidine (Sigma Chemical Co.) by incubating the cultures at room temperature for 15 min.
Flow cytometric analysis
Before staining, the cell suspensions were filtered through a 40-mm nylon cell strainer (Becton Dickinson and Co., Franklin Lakes, NJ) to remove clumps. Preparations of 5 ϫ 10 5 cells were preincubated with purified rat antimouse CD16/CD32 Fc Block (PharMingen, San Diego, CA) or 5% mouse serum (Sigma Chemical Co.) to minimize nonspecific binding. After the initial incubation, cells were stained with the designated fluorescein isothiocyanate-or phycoerythrin-conjugated mAB or subclass control for 30 min at 4 C and then washed with HBSS (BioWhittaker, Inc., Walkersville, MD). All cells were resuspended in Sorter Medium (Quality Biological, Gaithersburg, MD) for analysis. Cultured cells stained with fluorescent-conjugated antibodies were titrated (0.5-1 g/1 ϫ 10 6 cells) with the appropriate subclass controls. Samples were analyzed by flow cytometry using a FACSort (Becton Dickinson and Co.) with CellQuest software (Becton Dickinson and Co.). Five parameters were analyzed: forward scatter, side scatter, and up to three-color fluorescence intensity. Regions were set using forward vs. side scatter. Propidium iodide was used to gate out the dead cells for single staining analyses. Ten thousand events of list mode data were collected.
Osteoclast formation assay
The bcl-X L /Tag cells (2000/well) were cultured with or without MC3T3 cells or PA6 stromal cells (5000/well) in 48-well plates for 7 days. Half of the medium was changed after 3 days. Various concentrations of osteotropic hormones and growth factors were added at the beginning of the culture and at the time of medium change. On day 7, cells were fixed with 2% glutaraldehyde in PBS for 20 min, and the cells were stained for TRAP using an immunohistochemical kit (Sigma Chemical Co.). TRAP-positive MNC containing at least three nuclei were counted as OCL-like cells.
Pit formation assay
PA6 stromal cells or MC3T3 cells (10,000/dentine slice) were plated on dentine slices in a 24-well plate containing 1 slice/well. In some cultures, no stromal cells were added to the dentine slice. On the following day, 5,000 bcl-X L /Tag cells were added to each dentine slice, and the cells were cultured for 7 days in the presence of 1,25-(OH) 2 D 3 (2 ϫ 10 Ϫ9 m) and dexamethasone (10 Ϫ7 m). Half of the medium was changed every third day. After 7 days of culture, the medium was removed, and fresh medium containing various cytokines or hormones, e.g. IL-1␤, TNF␣, and PTHrP, were added to the cultures to test their effects on the resorption activity of MNC formed on dentine slices. After 24 -48 h, the cells were fixed with 2% glutaraldehyde in PBS for 20 min and stained for TRAP using an immunohistochemical kit (Sigma Chemical Co.). TRAP-positive MNC containing at least three nuclei were counted as OCL-like cells. The cells were then removed from the dentine by brushing, and the resorption lacunae were stained with 1% toluidine blue (10) . The number of resorption lacunae and the total resorption areas were measured using a phase contrast microscope and image analysis software (Bioquant, Nashville, TN) as described previously (11) .
Results
Surface phenotype of bcl-X L /Tag cells
Immunostaining of bcl-X L /Tag cells with the mAB against Mac-1 showed strong reactivity with these cells (Fig. 1A) . In (Table 1 and Fig. 2 ).
Immunofluorescent staining followed by flow cytometry was used to analyze the surface antigens expressed on bcl-X L /Tag cells. For each analysis we compared staining of MC3T3E1 feeders alone to that of bcl-X L /Tag cultured over feeder layers. Figure 3 shows the surface phenotype of bcl-X L /Tag cells. The cells expressed the common leukocyte antigen CD45.2 and the mouse Fc␥III and Fc␥II (CD16/ CD32) receptors. Staining with a panel of myeloid markers was variable. The bcl-X L /Tag cells expressed CD11b (Mac-1), but were negative for Mac-3 and CD11c. A very small subpopulation of the cells (ϳ10%) expressed low levels of F4/80 and CD14. The cells were also negative for the granulocyte marker Gr-1. Interestingly, bcl-X L /Tag cells were stained with mAB against costimulatory molecule B7-2 (CD86), but were negative for B7-1 (CD80) and CD40. The bcl-X L /Tag cells were also positive for MHC I, but not for MHC II (data not shown).
The doubling time of bcl-X L /Tag cells cultured over MC3T3E1 cells was approximately 24 h, based on the increase of Mac-1-positive cells in the cocultures (Fig. 4) . A cell concentration of 1 ϫ 10 5 Mac-1-positive cells/ml was optimal for growth.
RT-PCR analysis showed that MC3T3E1 cells (feeders) alone and highly purified bcl-X L /Tag cells cultured in the absence of feeders and treated with or without 1,25-(OH) 2 (Fig. 5) . (Fig. 5) . However, when these two factors were combined, TRAP-positive MNC formation was stimulated almost 200-fold compared with that in control cultures. In contrast, human IL-1␤ (10 ng/ml) only stimulated OCL-like cell formation in the presence of PA6 cells, and this increase was 7-fold compared with that in control cultures. Interestingly, when dexamethasone (10 Ϫ7 m) was combined with human IL-1␤ (10 ng/ml), TRAP-positive MNC formation was significantly enhanced 11-to 15-fold with or without PA6 stromal cells (data not shown). Surprisingly, PTH/PTHrP (1-100 ng/ml) and PGE 2 (10 Ϫ8 -10 Ϫ6 m) did not have any effect on TRAP-positive MNC formation (Fig. 6) . The effects of PTHrP on OCL formation by bcl-X L / Tag cells were also tested in the presence of primary rat osteoblasts (5000 cells/well in 48-well plates), but there were no significant effects on MNC formation (data not shown). This result was not due to a lack of PTHrP responsiveness of the fetal rat calvarial cells used in these assays. Treatment of these fetal rat calvarial cells with 100 g/ml PTHrP for 24 h increased cAMP production 5-fold from 3.75 to 18.75 mm/ 5 ϫ 10 4 cells plated. Furthermore, PTHrP induced OCL formation in cocultures of mouse spleen cells with these fetal rat calvarial cells (data not shown). Calcitonin (10 -100 mU/ml) dose dependently inhibited TRAP-positive MNC formation in 1,25-(OH) 2 D 3 -stimulated cultures with or without PA6 stromal cells (Fig. 7) . One thousand purified bcl-X L /Tag cells were cultured in the absence of an MC3T3 feeder layer for 7 days as described in Materials and Methods. Results represent the mean Ϯ SEM for four determinations. A similar pattern of results was seen in two independent experiments. greater than 500 times that reported for normal mouse marrow cultures (12) . A high level of OCL formation was seen when the cells were grown over MC3T3E1 cells or PA6 cells. MC3T3E1 cells have been reported not to support OCL formation (13), but in our hands, these cells supported the growth of bcl-X L /Tag cells without inducing their differentiation. In contrast, PA6 cells induce the differentiation of bcl-X L cells and did not support their continued growth (7) . These data demonstrate an important role for marrow stro- OCL precursor growth and differentiation, as neither GM-CSF nor M-CSF induced expression of the F4/80 antigen on bcl-X L /Tag cells that were grown in the presence of osteoblastic cells.
Osteotropic factor responsivity of bcl-X L /Tag cells
Bone-resorbing capacity of bcl-X L /Tag cells
Calcitonin (10 -100 mU/ml) dose dependently inhibited OCL-like cell formation by 30 -60% in bcl-X L /Tag cells that were treated with 1,25-(OH) 2 D 3 . This is the same degree of inhibition of OCL formation (64% with calcitonin, 100 mU/ ml) induced by calcitonin in normal marrow cultures (12) .
The bcl-X L cells differ from OCL precursors in normal marrow in several ways. PTH or PTHrP did not stimulate OCL formation by bcl-X L /Tag cells regardless of they were grown over PA6 cells or primary rat osteoblasts. Udagawa and co-workers (13) have shown that PA6 cells do not respond to PTH or PTHrP and that the effects of PTH or PTHrP on OCL formation are indirect, most likely by induction of RANK ligand. It was not surprising that PTH and PTHrP had no effect on bcl-X L /Tag cells when they were grown over PA6 cells or MC3T3E1 cells, as neither cell type responds to PTHrP. However, the failure of these cells to form OCLs in response to PTHrP when cocultured with primary rat osteoblasts was unexpected. We have shown in preliminary studies that bcl-X L /Tag cells constitutively express the RANK receptor. Thus, the exact mechanism of why these cells fail to respond to PTH when cocultured with primary rat osteoblasts remains to be determined.
Surface phenotype analysis of bcl-X L /Tag cells confirms that they are derived from the monocyte-macrophage lineage. Miyamato and co-workers (15) recently developed and characterized a macrophage cell line (C7) that had some osteoclastic characteristics. However, only 4 -7% of these mononuclear cells were able to differentiate into OCLs. This antigen, which is expressed on the surface of B cells. Importantly, the OCL formation capacity of our cell line (ϳ50%) was much higher than that of the C7 macrophage cell line. Another macrophage cell line, BDM-1, has been reported that has a 5-9% efficiency in OCL formation capacity (16) . Chambers and his co-workers (17) also used a transgenic mouse approach for developing an OCL cell line. They produced mice transgenic for temperature-sensitive simian virus 40 large T antigen gene driven by an interferon-inducible MHC complex H-2K b promoter. This cell line was able to differentiate to both macrophages and OCLs, and its initial OCL formation capacity was approximately 2.5% (Chambers, T. J., personal communication). Recently, Chen et al. (18) reported the generation of a murine osteoclastogenic cell line (MDCP-5) by targeting large T antigen to marrow cells cocultured over an OCL-inductive marrow stromal cell line. This cell line also expressed macrophage markers and formed OCLs at a high efficiency, analogous to our results.
The bone-resorptive capacity of OCLs formed by bcl-X L / Tag cells was similar to that reported for primary rat OCLs. The resorption area per mature rat OCL after 24 h of culture has been reported to be 968 Ϯ 145 m 2 . There were approximately 220 Ϯ 21 OCLs/bone slice (19) . These data are very similar to the 255 OCLs and 836 Ϯ 144 m 2 resorption area/ OCL formed by bcl-X L /Tag cells.
In summary, the bcl-X L /Tag cells respond appropriately to most osteotropic hormones and cytokines, although they do not respond to PTH or PGE 2 , which are potent stimulators of normal OCL formation (Table 2) . Aside from these caveats, bcl-X L /Tag cells appear to be an appropriate model to study interactions between osteoblast and OCL precursors as well as to examine the molecular events associated with OCL differentiation and bone resorption. Furthermore, in preliminary studies, we demonstrated that bcl-X L /Tag cells can be transfected by adenoviral or retroviral vectors with a transfection efficiency of 20 -40%, respectively. These data suggest that bcl-X L /Tag cells can be used to examine differences at the molecular level that occur with commitment to the OCL lineage or terminal differentiation to the macrophage lineage. Such studies should provide important insights into the molecular events controlling OCL formation and activity.
